Healthcare entity
All 1 tracked stories fall under one category: market-trends. 4D Medical is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 5 original sources per story, versus 4 across the same-window beat baseline.
Last mentioned: Feb 25, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: market-trends. 4D Medical is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 5 original sources per story, versus 4 across the same-window beat baseline. At 6, the average consequence score sits above the same-window beat average of 5.7. Mesoblast appears in 1 tracked Healthcare story from February 25, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 31 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Mesoblast. Shared-story counts are live from our verified record — not editorial picks.
The global healthcare sector is bifurcating as mid-cap biotech innovators outperform established heavyweights despite regulatory headwinds from the Trump administration. While the ASX 200 healthcare index fell 25% in 2025, a surge in capital raising and AI integration is fueling a resilient 'engine room' of drug discovery and device innovation.
Source: 0 Comments (au) · 0 Comments (au)
Mesoblast is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
